Sumitomo Mitsui Trust Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.2M | Buy |
894,303
+29,996
| +3% | +$1.08M | 0.02% | 571 |
|
|
2025
Q1 | $26.9M | Sell |
864,307
-88,416
| -9% | -$2.75M | 0.02% | 593 |
|
|
2024
Q4 | $24.3M | Sell |
952,723
-56,818
| -6% | -$1.45M | 0.02% | 616 |
|
|
2024
Q3 | $28.6M | Buy |
1,009,541
+15,963
| +2% | +$452K | 0.02% | 589 |
|
|
2024
Q2 | $26.2M | Buy |
993,578
+62,218
| +7% | +$1.64M | 0.02% | 593 |
|
|
2024
Q1 | $28.3M | Sell |
931,360
-87,266
| -9% | -$2.65M | 0.02% | 641 |
|
|
2023
Q4 | $28.6M | Sell |
1,018,626
-286,133
| -22% | -$8.04M | 0.02% | 634 |
|
|
2023
Q3 | $35.4M | Sell |
1,304,759
-1,130
| -0.1% | -$30.7K | 0.03% | 552 |
|
|
2023
Q2 | $40.1M | Buy |
1,305,889
+18,059
| +1% | +$555K | 0.03% | 535 |
|
|
2023
Q1 | $46.4M | Buy |
1,287,830
+279,667
| +28% | +$10.1M | 0.03% | 519 |
|
|
2022
Q4 | $39.8M | Buy |
1,008,163
+343
| +0% | +$13.6K | 0.03% | 554 |
|
|
2022
Q3 | $40.5M | Buy |
1,007,820
+3,586
| +0.4% | +$144K | 0.03% | 539 |
|
|
2022
Q2 | $42.2M | Buy |
1,004,234
+83,553
| +9% | +$3.51M | 0.03% | 564 |
|
|
2022
Q1 | $35.9M | Buy |
+920,681
| New | +$35.9M | 0.02% | 627 |
|